NCT03492996View on ClinicalTrials.gov

A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 21, 2020

Primary Completion Date

August 3, 2020

Study Completion Date

September 23, 2020

Conditions

Healthy

Interventions

DRUG

LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose

To assess the absorption, metabolism, excretion of LCB01-0371 after a single oral LCB01-0371 dose with a \[14C\]-LCB01-0371-tracer dose to healthy subjects

Trial Locations (1)

03080

Seoul National University Hospital, Seoul